Vaccine development strategies for improving immunization: the role of modern immunology

An ideal vaccine has certain biological and physical characteristics. Technological advances have provided new strategies that may help the design of such a vaccine.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1

    Levine, M.M., Campbell, J.D. & Kotloff, K.L. Br. Med. Bull. 62, 1–13 (2002).

  2. 2

    Kaech, S.M., Wherry, E.J. & Ahmed, R. Nat. Rev. Immunol. 2, 251–262 (2002).

  3. 3

    Sprent, J. & Surh, C.D. Annu. Rev. Immunol. 20, 551–579 (2002).

  4. 4

    Esser, M.T. et al. Vaccine 21, 419–430 (2003).

  5. 5

    Agematsu, K., Hokibara, S., Nagumo, H. & Komiyama, A. Immunol. Today 21, 204–206 (2000).

  6. 6

    Siegrist, C.A. Vaccine 19, 3331–3346 (2001).

  7. 7

    Levine, M.M. Nat. Med. 9, 99–103 (2003).

  8. 8

    Pizza, M. et al. Science 287, 1816–1820 (2000).

  9. 9

    Lowell, G.H. et al. Infect. Immun. 64, 4686–4693 (1996).

  10. 10

    Tacket, C.O. et al. Nat. Med. 4, 607–609 (1998).

  11. 11

    Hariharan, M.J. et al. J. Virol. 72, 950–958 (1998).

  12. 12

    Pasetti, M.F. et al. J. Virol. 77, 5209–5217 (2003).

  13. 13

    Takeda, K., Kaisho, T. & Akira, S. Annu. Rev. Immunol. 21, 335–376 (2003).

  14. 14

    Agren, L.C., Ekman, L., Lowenadler, B., Nedrud, J.G. & Lycke, N.Y. J. Immunol. 162, 2432–2440 (1999).

  15. 15

    Mills, K.H. et al. Infect. Immun. 71, 726–732 (2003).

  16. 16

    Guerena-Burgueno, F. et al. Infect. Immun. 70, 1874–1880 (2002).

Download references

Author information

Correspondence to Myron M Levine.

Rights and permissions

Reprints and Permissions

About this article

Further reading